steady revenue growth including revenue from its hybrid cloud platform, Red Hat software, consulting services, and product sales to Kyndryl.
In its first quarter ended March 31, IBM reported revenue of $14.20 billion, up nearly 8 percent year over year. Net income, however, declined more than 23 percent to $733 million.
In January IBM struck a deal to sell its health-care data and analytics assets, including Health Insights, MarketScan and Micromedex, to global investment firm Francisco Partners